ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Clym Adds HIPAA Authorization to Its Consent Management Platform

-- Clym has announced the release of HIPAA Authorization for Healthcare Web Tracking Consent, a new capability designed to help healthcare organizations manage consent for online tracking activities involving health-related data. The launch addresses a growing challenge as healthcare websites increasingly relyon analytics and third-party services that may involve protected health information.


Standard cookie consent tools were developed primarily for general consumer privacy laws and are not designed to capture HIPAA-specific authorization requirements. As a result, healthcare organizations often face gaps between how website consent is collected and how HIPAA authorization is expected to be handled when health-related data is disclosed to third parties.

“HIPAA authorization requires a different approach than traditional cookie consent,” said a Clym spokesperson. “This release is focused on giving healthcare organizations a clearer way to manage authorization for web tracking activities within their broader consent workflows.”

The new capability extends Clym’s broader consent management system, allowing organizations to handle HIPAA authorization alongside cookie consent, marketing preferences, and advertising consent frameworks. Through the same interface, teams can manage controls for tracking technologies and advertising signals such as Google Consent Mode V2, with configurations applied automatically and without the need for manual or technical setup.

This approach reflects Clym’s all-in-one digital compliance solution, bringing consent management, accessibility tools, and transparency features into one platform. Consolidating these functions helps organizations reduce the need for multiple vendors while maintaining clearer oversight of digital compliance activities.

The announcement comes as regulators and privacy experts continue to scrutinize how health-related data is collected and shared online. According to the U.S. Department of Health and Human Services, hundreds of large healthcare data breaches affecting tens of millions of individuals were recorded in 2025, highlighting the sensitivity of healthcare data in digital environments.

Contact Info:
Name: Clym Inc.
Email: Send Email
Organization: Clym
Website: https://clym.io

Release ID: 89183654

If there are any deficiencies, discrepancies, or concerns regarding the information presented in this press release, we kindly request that you promptly inform us by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team is committed to addressing any identified issues within 8 hours to guarantee the delivery of accurate and reliable content to our esteemed readers.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.11
+5.25 (2.56%)
AAPL  264.58
+4.00 (1.54%)
AMD  200.15
-3.22 (-1.58%)
BAC  53.06
+0.29 (0.55%)
GOOG  314.90
+11.34 (3.74%)
META  655.66
+10.88 (1.69%)
MSFT  397.23
-1.23 (-0.31%)
NVDA  189.82
+1.92 (1.02%)
ORCL  148.08
-8.46 (-5.40%)
TSLA  411.82
+0.11 (0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.